Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American journal of translational research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 28979689PMCID PMC5622258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression

  2017cited by this paper
• CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms

  2017cited by this paper
• The Association Between C424c/A Polymorphism Within the IL-25 Gene and Multiple Sclerosis

  2016cited by this paper
• Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut

  2016cited by this paper
• The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.

  2016cited by this paper
• Calycosin suppresses expression of pro-inflammatory cytokines via the activation of p62/Nrf2-linked heme oxygenase 1 in rheumatoid arthritis synovial fibroblasts.

  2016cited by this paper
• Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype

  2016cited by this paper
• Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis

  2016cited by this paper
• The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis

  2016cited by this paper
• Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma

  2016cited by this paper
• Mesenchymal stem cells and immunomodulation: current status and future prospects

  2016cited by this paper
• Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy

  2016cited by this paper
• Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism

  2016cited by this paper
• IL-25 Promotes Th2 Immunity Responses in Asthmatic Mice via Nuocytes Activation

  2016cited by this paper
• Interleukin‐25 initiates Th2 differentiation of human CD4+ T cells and influences expression of its own receptor

  2015cited by this paper
• The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus

  2015cited by this paper
• IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice

  2015cited by this paper
• Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease

  2015cited by this paper
• Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis

  2015cited by this paper
• Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells

  2014cited by this paper
• Inflammatory bowel disease: pathogenesis.

  2014cited by this paper
• Inflammatory bowel disease: clinical aspects and treatments

  2014cited by this paper
• The Life and Fate of Mesenchymal Stem Cells

  2014cited by this paper
• Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.

  2014cited by this paper
• Innate and adaptive immunity in inflammatory bowel disease.

  2014cited by this paper
• Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation

  2014cited by this paper
• Mesenchymal stromal cells: sensors and switchers of inflammation.

  2013cited by this paper
• Immune aspects of the pathogenesis of inflammatory bowel disease.

  2013cited by this paper
• IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells

  2013cited by this paper
• Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

  2013cited by this paper
• IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel Disease

  2013cited by this paper
• Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.

  2013cited by this paper
• Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

  2012cited by this paper
• Innate and adaptive immunity in inflammatory bowel disease.

  2011cited by this paper
• Interleukin-25: key regulator of inflammatory and autoimmune diseases.

  2011cited by this paper
• Pretreatment with Interferon‐γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis

  2011cited by this paper
• Interleukin-25 negatively controls pathogenic responses in the gut.

  2011cited by this paper
• The dual role of interleukin-25 in the control of immune-mediated pathologies.

  2011cited by this paper
• Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease*

  2011cited by this paper
• Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing

  2010cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.

  2009cited by this paper
• Variations of Clonal Marrow Stem Cell Lines Established from Human Bone Marrow in Surface Epitopes, Differentiation Potential, Gene Expression, and Cytokine Secretion

  2008cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003cited by this paper
• Interleukin-25 (OR IL-17E): A New IL-17 Family Member with Growth Factor/Inflammatory Actions

  2003cited by this paper
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone.

  2001cited by this paper
• Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)‐induced colitis

  2000influential reference
• Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells

  1998cited by this paper
• Case of crohn's disease in bone marrow transplantation

  1993cited by this paper

• Lack of IFN-γ response of human uterine myometrium-derived MSCs significantly improve multiple IBD parameters compared to bone marrow MSCs: implications for anti-TNFα-refractory patients.

  2025cites this paper
• Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis

  2024cites this paper
• Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis

  2024cites this paper
• MSCs Ameliorate Hepatic IR Injury by Modulating Phenotypic Transformation of Kupffer Cells Through Drp-1 Dependent Mitochondrial Dynamics

  2023cites this paper
• Enhancers of mesenchymal stem cell stemness and therapeutic potency.

  2023cites this paper
• Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune/inflammatory diseases

  2023cites this paper
• Interleukin 25 and its biological features and function in intestinal diseases

  2023cites this paper
• Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression

  2023cites this paper
• Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

  2023cites this paper
• Preliminary exploration of inulin and inulin liposome on DSS-induced colitis remission

  2023cites this paper
• Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers

  2023cites this paper
• Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function

  2022cites this paper
• Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases

  2022cites this paper
• Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects

  2022cites this paper
• Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases?

  2022cites this paper
• Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges

  2022cites this paper
• Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?

  2021cites this paper
• Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases

  2021cites this paper
• Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases

  2021cites this paper
• Type 2 immunity in intestinal homeostasis and inflammatory bowel disease

  2021cites this paper
• Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases

  2021cites this paper
• Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application

  2020cites this paper
• TNF-α Priming Elicits Robust Immunomodulatory Potential of Human Tonsil-Derived Mesenchymal Stem Cells to Alleviate Murine Colitis

  2020cites this paper
• Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases

  2020cites this paper
• Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review

  2019cites this paper
• Mesenchymal Stem Cell Functionalization for Enhanced Therapeutic Applications

  2019cites this paper
• Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway

  2019cites this paper
• Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases

  2019cites this paper
• Preconditioning with interleukin‐1 beta and interferon‐gamma enhances the efficacy of human umbilical cord blood‐derived mesenchymal stem cells‐based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3‐dioxygenase activity in dextran sulfate sodium‐induced colitis

  2019cites this paper
• Concise Review: Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era?

  2019cites this paper
• Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF‐κB pathway and ROS signaling

  2018cites this paper
• Endoscopic submucosal injection of adipose-derived mesenchymal stem cells ameliorates TNBS-induced colitis in rats and prevents stenosis

  2018cites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• World Journal of Stem Cells

  year unknowncites this paper